Larvol Delta - Retrotope-Granted-Rare-Pediatric-Disease-Designation-from-FDA-for-Lead-Development-Candidate-RT001-in-Two-LifeThreatening-Neurodegenerative-Indications

RT001 - Retrotope

https://www.globenewswire.com/news-release/2021/02/25/2182264/0/en/Retrotope-Granted-Rare-Pediatric-Disease-Designation-from-FDA-for-Lead-Development-Candidate-RT001-in-Two-Life-Threatening-Neurodegenerative-Indications.html

Feb 25, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next